| Revision as of 19:45, 20 September 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (repo← Previous edit |
Latest revision as of 13:32, 26 October 2023 edit undoVsmith (talk | contribs)Administrators272,247 editsmNo edit summary |
| (21 intermediate revisions by 17 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
|
| verifiedrevid = 449582819 |
|
| verifiedrevid = 451554162 |
|
| IUPAC_name = 1-phenyl-1-cyclohexyl-3-dimethylaminopropane |
|
| IUPAC_name = 1-phenyl-1-cyclohexyl-3-dimethylaminopropane |
|
| image = Gamfexine.png |
|
| image = Gamfexine.png |
|
|
|
|
<!--Clinical data--> |
|
<!--Clinical data--> |
|
| tradename = |
|
| tradename = |
| Line 9: |
Line 10: |
|
| legal_status = Unscheduled |
|
| legal_status = Unscheduled |
|
| routes_of_administration = Oral |
|
| routes_of_administration = Oral |
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!--Pharmacokinetic data--> |
|
| bioavailability = |
|
| bioavailability = |
| Line 15: |
Line 15: |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
| ⚫ |
| CAS_number = 7273-99-6 |
|
|
| ATC_prefix = none |
|
| ATC_prefix = none |
|
| ATC_suffix = |
|
| ATC_suffix = |
| Line 25: |
Line 24: |
|
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
| KEGG = D04298 |
|
| KEGG = D04298 |
|
⚫ |
| CAS_number = 7273-99-6 |
|
|
|
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
|
| ChemSpiderID = 28799 |
|
|
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChI = 1S/C17H27N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3 |
|
|
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChIKey = AJDSHXKJJDQZCJ-UHFFFAOYSA-N |
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=17 | H=27 | N=1 |
|
| C=17 | H=27 | N=1 |
|
| molecular_weight = 245.402 g/mol |
|
|
| smiles = c1ccccc1C(CCN(C)C)C2CCCCC2 |
|
| smiles = c1ccccc1C(CCN(C)C)C2CCCCC2 |
|
}} |
|
}} |
|
|
|
|
|
'''Gamfexine''' ('''WIN-1,344''') is a centrally-acting ] ], which was tested as an adjunct treatment for withdrawn schizophrenic patients, but while effective for treating withdrawal it made psychotic symptoms worse.<ref>John H Biel. Annual Reports in Medicinal Chemistry, Volume 2. Academic Press 1966. p18.</ref> |
|
'''Gamfexine''' ('''WIN-1,344''') is a centrally acting ] ], which was tested as an adjunct treatment for withdrawn patients with ], but while effective for treating withdrawal it made psychotic symptoms worse.<ref>{{cite journal | vauthors = Biel JH | title = Antidepressants, Stimulants, Hallucinogens. | journal = Annual Reports in Medicinal Chemistry | date = January 1967 | volume = 2 | pages = 11–23 (18) | publisher = Academic Press | doi = 10.1016/S0065-7743(08)61499-2 }}</ref> |
|
|
|
|
|
==See also== |
|
|
*] |
|
|
|
|
|
== References == |
|
== References == |
|
{{Reflist}} |
|
{{Reflist}} |
|
|
|
|
|
|
|
|
{{Stimulants}} |
|
{{Stimulants}} |
| Line 42: |
Line 48: |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
|
|
|
|
|
|
|